Joke Devoldere
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Retinal Development and Disorders 8
- RNA Interference and Gene Delivery 6
- RNA regulation and disease 2
-
- Retinal and Macular Surgery 4
- Co-authors
- Katrien Remaut (12 shared papers)Stefaan C. De Smedt (12 shared papers)Karen Peynshaert (10 shared papers)Heleen Dewitte (3 shared papers)An‐Katrien Minnaert (3 shared papers)Christian Vanhove (2 shared papers)Shirin Tavakoli (1 shared paper)Eva M. del Amo (1 shared paper)
In The Last Decade
Joke Devoldere
12 papers receiving 573 citations
Peers
Comparison fields: 5 of 68
- Ophthalmology 160
- Pharmaceutical Science 64
- Radiology, Nuclear Medicine and Imaging 145
- Molecular Biology 367
- Public Health, Environmental and Occupational Health 79
Countries citing papers authored by Joke Devoldere
This map shows the geographic impact of Joke Devoldere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke Devoldere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke Devoldere more than expected).
Fields of papers citing papers by Joke Devoldere
This network shows the impact of papers produced by Joke Devoldere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke Devoldere. The network helps show where Joke Devoldere may publish in the future.
Co-authors
The 25 scholars most cited alongside Joke Devoldere, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 103 | |
| 2 | 2015 | 96 | |
| 3 | 2020 | 89 | |
| 4 | 2019 | 69 | |
| 5 | 2019 | 59 | |
| 6 | 2019 | 50 | |
| 7 | 2017 | 49 | |
| 8 | 2021 | 28 | |
| 9 | 2019 | 23 | |
| 10 | 2020 | 6 | |
| 11 | 2021 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2024 | 0 |
About Joke Devoldere
Joke Devoldere is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Ophthalmology, Genetics and Cellular and Molecular Neuroscience, having authored 13 papers that have together received 580 indexed citations. Recurring topics across this work include Retinal Development and Disorders (8 papers), RNA Interference and Gene Delivery (6 papers), Retinal and Macular Surgery (4 papers), Virus-based gene therapy research (4 papers), Retinal Diseases and Treatments (3 papers), RNA regulation and disease (2 papers), Glaucoma and retinal disorders (1 paper) and Neuroscience and Neural Engineering (1 paper). The work is most often cited by research in Ophthalmology (160 citations), Pharmaceutical Science (64 citations), Radiology, Nuclear Medicine and Imaging (145 citations), Molecular Biology (367 citations) and Public Health, Environmental and Occupational Health (79 citations). Joke Devoldere has collaborated with scholars based in Belgium, France and Türkiye. Frequent co-authors include Katrien Remaut, Stefaan C. De Smedt, Karen Peynshaert, Heleen Dewitte, An‐Katrien Minnaert, Christian Vanhove, Shirin Tavakoli, Eva M. del Amo, Marika Ruponen and Tatu Lajunen. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Drug Discovery Today, Journal of Controlled Release, Drug Delivery and Expert Opinion on Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.